Polyclonal Rabbit anti‑Human LRFN2 Antibody (PE, aa630‑659, WB) LS‑C207195
Polyclonal Rabbit anti‑Human LRFN2 Antibody (PE, aa630‑659, WB) LS‑C207195
Antibody:
LRFN2 Rabbit anti-Human Polyclonal (aa630-659) (PE) Antibody
Format:
Phycoerythrin, Unmodified
Overview
Antibody:
LRFN2 Rabbit anti-Human Polyclonal (aa630-659) (PE) Antibody
Format:
Phycoerythrin, Unmodified
Specifications
Description
LRFN2 antibody LS-C207195 is a PE-conjugated rabbit polyclonal antibody to human LRFN2 (aa630-659). Validated for ELISA and WB.
Target
Human LRFN2
Synonyms
LRFN2 | FIGLER2 | KIAA1246 | RP11-535K1.2 | SALM1
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Phycoerythrin.
Also available
Unconjugated or conjugated with
AP,
APC,
Biotin,
FITC,
HRP.
Purification
Protein A purified
Specificity
This LRFN2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 630-659 amino acids from the C-terminal region of human LRFN2.
Applications
- Western blot
- ELISA
- Applications tested for the base form of this product only
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, No preservatives added
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Reactivity:
Human
Range:
1.22-300 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 3/23/2023